Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Pathology and Forensic Medicine
Reference92 articles.
1. Beyond histology: translating tumor genotypes into clinically effective targeted therapies;Meador;Clin Cancer Res,2014
2. A new initiative on precision medicine;Collins;N Engl J Med,2015
3. The precision medicine initiative: a new national effort;Ashley;JAMA,2015
4. Comprehensive molecular portraits of human breast tumours;Nature,2012
5. Lessons from the cancer genome;Garraway;Cell,2013
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer;British Journal of Cancer;2024-05-17
2. Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer;Breast Cancer Research and Treatment;2024-03-24
3. Age and race/ethnicity differences in decisional conflict in women diagnosed with ductal carcinoma in situ;BMC Women's Health;2024-02-04
4. Proteomics-Based Identification of Dysregulated Proteins and Biomarker Discovery in Invasive Ductal Carcinoma, the Most Common Breast Cancer Subtype;Proteomes;2023-04-03
5. A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity;Cancers;2022-11-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3